MedSchool: Ace Your OSCEsThe Medical Company
GET - On the App Store
Drug Guide


    A prodrug that requires enzymatic activation
  • Mechanism of Action

  • Irreversibly inhibits the binding of adenosine diphosphate (ADP) to platelet P2Y₁₂ receptors, resulting in reduced platelet activation and aggregation.
  • Pharmacology

  • A pro-drug that requires enzymatic activation.

Clinical Use

  • Indications
  • Acute coronary syndrome (in conjunction with aspirin)
  • Prevention of in-stent thrombosis following percutaneous coronary intervention
  • Prevention of vascular ischaemia following stroke, MI or peripheral vascular disease
  • Contraindications
  • Active bleeding
  • Intracranial haemorrhage
  • Adverse Effects

  • Haemorrhage.
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Sign Up Now

Snapshot: Initialising...